Michael F. Cannon is the Cato Institute’s director of health policy studies. Cannon is “an influential health‐care wonk” (Washington Post), “ObamaCare’s single most relentless antagonist” (New Republic), “ObamaCare’s fiercest critic” (The Week), “the intellectual father” of King v. Burwell (Modern Healthcare), and “the most famous libertarian health care scholar” (Washington Examiner). Washingtonian magazine named Cannon one of Washington D.C.’s “Most Influential People” in both 2021 and 2022.
Cannon has appeared on ABC, Al Jazeera, BBC, CBS, CNN, CNBC, C‑SPAN, Fox News Channel, NPR, and other broadcast media. His articles have appeared in the Wall Street Journal; the New York Times; USA Today; the Washington Post; the Los Angeles Times; the New York Post; the Chicago Tribune; the Chicago Sun‐Times; the San Francisco Chronicle; SCOTUSBlog; Huffington Post; Forum for Health Economics and Policy; JAMA Internal Medicine; Health Matrix: Journal of Law‐Medicine; Harvard Health Policy Review; the Yale Journal of Health Policy, Law, and Ethics; the Journal of Health Politics, Policy and Law; and Quinnipiac Health Law Journal.
Cannon is the coeditor of Replacing Obamacare: The Cato Institute on Health Care Reform, author of 50 Vetoes: How States Can Stop the Obama Health Care Law, and coauthor of Healthy Competition: What’s Holding Back Health Care and How to Free It. Previously, he served as a domestic policy analyst for the U.S. Senate Republican Policy Committee, where he advised the Senate leadership on health, education, labor, welfare, and the Second Amendment.
Cannon holds an MA in economics and a JM in law and economics from George Mason University and a BA in American government from the University of Virginia. He is a member of the Board of Advisers of Harvard Health Policy Review and the Federalist Society Regulatory Transparency Project’s FDA & Health Working Group.
*****
A person listed as a contributor has spoken or otherwise participated in Federalist Society events, publications, or multimedia presentations. A person's appearance on this list does not imply any other endorsement or relationship between the person and the Federalist Society. In most cases, the biographical information on a person's "contributor" page is provided directly by the person, and the Federalist Society does not edit or otherwise endorse that information. The Federalist Society takes no position on particular legal or public policy issues. All expressions of opinion by a contributor are those of the contributor.
What COVID-19 Revealed about Clinician Licensing
Washington & Lee Student Chapter
Washington and Lee School of Law, Sydney Lewis HallE Denny Circle
Lexington, VA 24450
FDA Policy and the Covid-19 Pandemic
Duke Student Chapter
Zoom Webinar -- DukeVirtual
Durham, NC 27708
Legal Challenges to the ACA
Brigham Young Student Chapter
Zoom Webinar -- BYU341 E Campus Drive
Provo, UT 84602
Missouri Medicaid Expansion Debate
St. Louis Student Chapter
Zoom Webinar -- St. Louis100 N. Tucker Boulevard
Saint Louis, MO 63101
Explainer Episode 45 - Telehealth & COVID-19
Regulatory Transparency Project's Fourth Branch Podcast
In this podcast episode, Michael Cannon, Director of Health Policy Studies at Cato Institute and...
Explainer Episode 41 - Government Obstacles to Over The Counter Medicines
Regulatory Transparency Project's Fourth Branch Podcast
The Goldwater Institute’s Christina Sandefur moderates a discussion with the Cato Institute’s director of health...
Explainer Episode 39 - Tax Exclusions for Employer-Sponsored Health Insurance
Regulatory Transparency Project's Fourth Branch Podcast
In this episode, Michael F. Cannon argues that the federal income tax exclusion of employer-sponsored...
Deep Dive Episode 209 – Who Should Decide Whether Drugs Are Available Over-The-Counter or by Prescription?
Regulatory Transparency Project's Fourth Branch Podcast
In October 2020, Michael Cannon and Jeffrey Singer proposed ending the U.S. Food and Drug...
Who Should Decide Whether Drugs Are Available Over-The-Counter or by Prescription?
In October 2020, Michael Cannon and Jeffrey Singer proposed ending the U.S. Food and Drug...